Seppo Meri

22.7k total citations · 2 hit papers
389 papers, 17.4k citations indexed

About

Seppo Meri is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, Seppo Meri has authored 389 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Immunology, 77 papers in Hematology and 56 papers in Epidemiology. Recurrent topics in Seppo Meri's work include Complement system in diseases (155 papers), Platelet Disorders and Treatments (28 papers) and Blood groups and transfusion (27 papers). Seppo Meri is often cited by papers focused on Complement system in diseases (155 papers), Platelet Disorders and Treatments (28 papers) and Blood groups and transfusion (27 papers). Seppo Meri collaborates with scholars based in Finland, Germany and United States. Seppo Meri's co-authors include T. Sakari Jokiranta, Peter F. Zipfel, Hanna Jarva, Michael K. Pangburn, Jens Hellwage, Taru Meri, B. Paul Morgan, Markus J. Lehtinen, Antti Väkevä and Juha Hakulinen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Seppo Meri

380 papers receiving 17.0k citations

Hit Papers

Intracellular Complement ... 2013 2026 2017 2021 2013 2020 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Seppo Meri 9.0k 3.0k 2.6k 2.5k 2.0k 389 17.4k
Anna M. Blom 6.9k 0.8× 2.9k 1.0× 2.0k 0.8× 1.9k 0.7× 1.5k 0.7× 357 13.8k
Peter F. Zipfel 13.0k 1.5× 3.8k 1.3× 3.1k 1.2× 4.4k 1.7× 4.4k 2.2× 386 22.6k
Peter Garred 11.2k 1.2× 2.5k 0.8× 2.5k 1.0× 2.4k 0.9× 2.0k 1.0× 416 17.2k
P Vassalli 10.2k 1.1× 6.1k 2.1× 2.5k 1.0× 1.6k 0.6× 1.4k 0.7× 209 22.4k
Daniel Ricklin 7.9k 0.9× 2.5k 0.8× 1.1k 0.4× 2.3k 0.9× 1.4k 0.7× 143 12.1k
Mohamed R. Daha 13.7k 1.5× 4.1k 1.4× 1.7k 0.7× 3.6k 1.4× 1.2k 0.6× 540 24.3k
Sergio Romagnani 20.6k 2.3× 4.7k 1.6× 3.7k 1.4× 1.3k 0.5× 1.8k 0.9× 350 36.0k
Matthias Mack 13.3k 1.5× 5.9k 2.0× 2.9k 1.1× 647 0.3× 2.9k 1.4× 259 25.3k
Hans J. Müller‐Eberhard 15.6k 1.7× 5.7k 1.9× 1.7k 0.7× 7.0k 2.8× 1.3k 0.6× 283 25.1k
Enrico Maggi 15.6k 1.7× 3.6k 1.2× 2.6k 1.0× 1.0k 0.4× 1.2k 0.6× 367 27.2k

Countries citing papers authored by Seppo Meri

Since Specialization
Citations

This map shows the geographic impact of Seppo Meri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seppo Meri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seppo Meri more than expected).

Fields of papers citing papers by Seppo Meri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seppo Meri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seppo Meri. The network helps show where Seppo Meri may publish in the future.

Co-authorship network of co-authors of Seppo Meri

This figure shows the co-authorship network connecting the top 25 collaborators of Seppo Meri. A scholar is included among the top collaborators of Seppo Meri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seppo Meri. Seppo Meri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pekkarinen, Pirkka T., et al.. (2025). Characterization of inherited C3 deficiency – a patient case. Immunobiology. 230(4). 153024–153024.
2.
Nissinen, Liisa, Elina Siljamäki, Pekka Rappu, et al.. (2025). Expression of C1q by Macrophages and Fibroblasts in Tumor Microenvironment Is Associated with Progression and Metastasis of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 145(11). 2854–2868.e4. 2 indexed citations
3.
Heikkinen‐Eloranta, Jenni, et al.. (2025). Pregnancy-related Thrombotic Microangiopathy has a spectrum of underlying causes. Pregnancy Hypertension. 40. 101212–101212. 1 indexed citations
4.
Krzyżewska, Eva, Marta Książczyk, Bartłomiej Dudek, et al.. (2024). Lipopolysaccharide with long O-antigen is crucial for Salmonella Enteritidis to evade complement activity and to facilitate bacterial survival in vivo in the Galleria mellonella infection model. Medical Microbiology and Immunology. 213(1). 8–8. 4 indexed citations
5.
Räisänen‐Sokolowski, Anne, et al.. (2023). Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy. Cells. 12(5). 712–712. 9 indexed citations
6.
Meri, Seppo, Elena Magrini, Alberto Mantovani, & Cecília Garlanda. (2023). The Yin Yang of Complement and Cancer. Cancer Immunology Research. 11(12). 1578–1588. 18 indexed citations
7.
Kaartinen, Kati, et al.. (2022). Vascular Occlusion in Kidney Biopsy Is Characteristic of Clinically Manifesting Thrombotic Microangiopathy. Journal of Clinical Medicine. 11(11). 3124–3124. 4 indexed citations
8.
Krzyżewska, Eva, Anu Haveri, C Hammer, et al.. (2022). Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents. Immunity Inflammation and Disease. 10(9). e679–e679. 3 indexed citations
9.
Riihilä, Pilvi, Sirkku Peltonen, Markku Kallajoki, et al.. (2022). Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers. 14(2). 305–305. 14 indexed citations
10.
Kant, Ravi, Lauri Kareinen, Teemu Smura, et al.. (2021). Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant. Viruses. 13(11). 2263–2263. 19 indexed citations
11.
Nissilä, Eija, Hanna Ruhanen, Martina B. Lorey, et al.. (2021). Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience. 24(6). 102535–102535. 6 indexed citations
12.
Vidilaseris, Keni, Ayman Khattab, Orquídea Ribeiro, et al.. (2021). Exploration of Pyrazolo[1,5‐a]pyrimidines as Membrane‐Bound Pyrophosphatase Inhibitors. ChemMedChem. 16(21). 3360–3367. 7 indexed citations
13.
Nissinen, Liisa, Pilvi Riihilä, Markku Kallajoki, et al.. (2021). C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 142(5). 1478–1488.e9. 35 indexed citations
14.
Komi, Daniel Elieh Ali, et al.. (2020). Mast cells and complement system: Ancient interactions between components of innate immunity. Allergy. 75(11). 2818–2828. 70 indexed citations
15.
Meri, Seppo, et al.. (2020). Streptococci and the complement system: interplay during infection, inflammation and autoimmunity. FEBS Letters. 594(16). 2570–2585. 22 indexed citations
16.
Meri, Seppo, et al.. (2020). Complement evasion strategies of Borrelia burgdorferi sensu lato. FEBS Letters. 594(16). 2645–2656. 29 indexed citations
17.
Vidilaseris, Keni, Alexandros Kiriazis, Ainoleena Turku, et al.. (2019). Asymmetry in catalysis by Thermotoga maritima membrane-bound pyrophosphatase demonstrated by a nonphosphorus allosteric inhibitor. Science Advances. 5(5). eaav7574–eaav7574. 17 indexed citations
18.
Sane, Jussi, Outi Laine, Satu Mäkelä, et al.. (2011). Complement activation in Puumala hantavirus infection correlates with disease severity. Annals of Medicine. 44(5). 468–475. 45 indexed citations
19.
Taskinen, Minna, Erkka Valo, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2010). Signal Transducers and Activators of Transcription 5a–Dependent Cross-talk between Follicular Lymphoma Cells and Tumor Microenvironment Characterizes a Group of Patients with Improved Outcome after R-CHOP. Clinical Cancer Research. 16(9). 2615–2623. 6 indexed citations
20.
Manuelian, Tamara, Jens Hellwage, Seppo Meri, et al.. (2003). Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. Journal of Clinical Investigation. 111(8). 1181–1190. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026